- Home
- IPDN vs SNGX Comparison
IPDN vs SNGX Comparison
Compare IPDN & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPDN
- SNGX
- Stock Information
- Founded
- IPDN 2003
- SNGX 1987
- Country
- IPDN United States
- SNGX United States
- Employees
- IPDN N/A
- SNGX N/A
- Industry
- IPDN EDP Services
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- IPDN Technology
- SNGX Health Care
- Exchange
- IPDN Nasdaq
- SNGX Nasdaq
- Market Cap
- IPDN 5.2M
- SNGX 4.3M
- IPO Year
- IPDN 2013
- SNGX 1987
- Fundamental
- Price
- IPDN $6.69
- SNGX $2.98
- Analyst Decision
- IPDN
- SNGX Strong Buy
- Analyst Count
- IPDN 0
- SNGX 1
- Target Price
- IPDN N/A
- SNGX $6.00
- AVG Volume (30 Days)
- IPDN 16.9M
- SNGX 12.6M
- Earning Date
- IPDN 08-14-2025
- SNGX 08-14-2025
- Dividend Yield
- IPDN N/A
- SNGX N/A
- EPS Growth
- IPDN N/A
- SNGX N/A
- EPS
- IPDN N/A
- SNGX N/A
- Revenue
- IPDN $6,459,379.00
- SNGX N/A
- Revenue This Year
- IPDN N/A
- SNGX N/A
- Revenue Next Year
- IPDN N/A
- SNGX N/A
- P/E Ratio
- IPDN N/A
- SNGX N/A
- Revenue Growth
- IPDN N/A
- SNGX N/A
- 52 Week Low
- IPDN $0.97
- SNGX $1.09
- 52 Week High
- IPDN $11.20
- SNGX $6.23
- Technical
- Relative Strength Index (RSI)
- IPDN 88.71
- SNGX 52.95
- Support Level
- IPDN $1.89
- SNGX $2.97
- Resistance Level
- IPDN $2.16
- SNGX $6.23
- Average True Range (ATR)
- IPDN 0.69
- SNGX 0.49
- MACD
- IPDN 0.28
- SNGX -0.09
- Stochastic Oscillator
- IPDN 53.63
- SNGX 17.34
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates majority of its revenue from TalentAlly Network Segment.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).